cnn semaglutide fails to slow progression of Alzheimer's in highly anticipated trials, Novo Nordisk says Semaglutide: The benefits and risks
Description
2012;14(3):R76
While Wegovy is generally safe, it can cause adverse reactions in some individuals
In 2025, the litigation strategy shifted from medical spas to large-scale 503B operators
In: Aesthetic Surgery Journal
Importantly, muscle-preservation narratives that ignore cardiovascular, hematologic, and neuropsychiatric dimensions risk appearing one-sided
While not yet approved for addiction treatment, GLP-1RAs hold significant potential in addressing addictions complex neurobiological underpinnings
